STANIPHARM is committed to transform ideas into reliable and cost-effective technologies for the manufacturing of drug substances and differentiated drug products that show improved clinical performances over existing formulations.

With an extensive know-how in Supercritical Fluid (SCF) Technology and also in either innovative or established "non-supercritical" pharmaceutical technologies, our team is fully dedicated to the development of scalable API manufacturing and formulation techniques that can be operated in compliance with the Good Manufacturing Practices.

We substantially invest in equipment, gradually upgrade our facilities and quality system to pharmaceutical standards and work in close collaboration with Equipment suppliers and Contract Manufacturing Companies so as to secure the development of our Supercritical Fluid Technology Platform into state-of-the-art pharmaceutical technologies.